Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Simvastatin in Multiple Myeloma
NCT00281476Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Feb 2006
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of simvastatin in multiple myeloma (MM), sponsored by Vejle Hospital. Primary endpoint: Response estimated by internationally approved criteria at 8 weeks. Started Feb 2006; status: completed.
02
Drugs
simvastatin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00281476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281476.